VR Logo

Aspira Pathlab & Diagnostics: Board Meeting Intimation for Un-Audited Financial Results Of The Company For The Quarter Ended June 30 2022 And Other Business Matters

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 inter alia to consider and approve the following: 1) Un-audited Financial Results of the Company for the quarter ended June 30 2022; and2) Variation/alteration of Preference Shareholders right by converting said unlisted Preference Shares into Compulsorily Convertible Preference Shares and issuance of Equity Shares arising on conversion thereof subject to approval of Preference Shareholders Equity Shareholders and such other regulatory statutory authority (ies) as may be required.3) To fix date time venue for the 49th Annual General Meeting of the Company.4) To fix Book Closure date for the purpose of 49th Annual General Meeting of the Company & other matters.

Click here to view PDF